pfizer glp-1 agonist While Lilly and Novo dominate today's $50B+ obesity market, is preparing a killer portfolio to steal the spotlight in 2030s GLP-1s & Beyond: Understanding Incretin
Description
GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease
As California ends Medicaid coverage for GLP-1 weight loss drugs likeWegovy and Zepbound, experts say the states advice to simply eat better isnt realistic for many patients.
Somehow, its becoming even harder to get a GLP-1.
A revolutionary 3 strain probiotic
Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines
)
